Metraipolis › archive › dc_f6ee5148f103

Identification of Potential Therapeutic Agents for Type I Interferonopathy Using iPSC-Based Disease Modeling — Europe PMC PMID:41026253

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41026253
DOI
10.1007/s10875-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-09T16:50:34.553Z
SHA-256 of the archived text
4cfeec97dafc815a988a154182a41dd59de9c7401b6c696fd401147dc2782dd3
Stable URL of this page
https://metraipolis.com/documento/dc_f6ee5148f103

How to cite

Identification of Potential Therapeutic Agents for Type I Interferonopathy Using iPSC-Based Disease Modeling — Europe PMC PMID:41026253 — Europe PMC (en), https://europepmc.org/article/MED/41026253 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f6ee5148f103 (Metraipolis archive dc_f6ee5148f103, sha256 4cfeec97dafc815a988a154182a41dd59de9c7401b6c696fd401147dc2782dd3)
BibTeX
@misc{dcf6ee5148f103,
  title = {Identification of Potential Therapeutic Agents for Type I Interferonopathy Using iPSC-Based Disease Modeling — Europe PMC PMID:41026253},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41026253},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f6ee5148f103; sha256 4cfeec97dafc815a988a154182a41dd59de9c7401b6c696fd401147dc2782dd3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41026253. Agents can read the archived copy with the MCP tool read_document.